This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
Need to harmonize traditional and modern medicine to combat alarming health problems
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations.
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
Subscribe To Our Newsletter & Stay Updated
